Cinnamon supplement for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This trial tests a cinnamon-based supplement (A1Cantus) to see if it helps lower blood sugar in people with type 2 diabetes. If you qualify, you'll get either the supplement or a placebo (a pill with no active ingredient) for a period of time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 21 and 75 years old.
- You have type 2 diabetes with an A1c (average blood sugar over 3 months) between 8 and 10.
- Your diabetes medications have been stable for at least 6 months.
- You speak English or Spanish and can give informed consent.
- No one else in your household can already be in this study.
- You must not have major diabetes complications like kidney disease, eye damage, or heart disease/stroke, and no severe health issues like cancer or a weakened immune system. Your BMI must be under 40, and you cannot be allergic to cinnamon.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how a special oral nutritional supplement affects the gut microbiome (the bacteria in your digestive system) in people with type 2 diabetes. You will swallow a small capsule that collects samples as it travels through your gut, helping researchers understand the changes.
This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.
This study tests a new medicine called LC-Z300-01 to see if it is safe and works well for people with type 2 diabetes. It may help lower blood sugar levels.
This study tests whether a specific beneficial bacteria supplement (called Lactobacillus paracasei LC19) can help control blood sugar in people with newly diagnosed type 2 diabetes. It may offer an option to manage diabetes without starting medication right away.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This early-stage trial tests a new drug called AMG 127 to see if it's safe and how the body handles it. Researchers will enroll both healthy volunteers and people with type 2 diabetes to understand how the drug works in different groups.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.